Efficacy and Safety of Oxycodone/Naloxone (Targin®) in Persistent Moderate to Severe Low Back Pain Following NSAIDs Treatment
Clinical trial NCT03768466 · COMPLETED
Trial details
- NCT number
- NCT03768466
- Sponsor
- Mundipharma Korea Ltd
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-21
- Primary completion
- 2020-02-20
- Enrollment
- 123
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.